Sorry, you need to enable JavaScript to visit this website.
Home Our Science Coronavirus disease (COVID-19) Resources All COVID-19 Updates

All COVID-19 Updates

* Tofacitinib is not approved or authorized for use in patients with COVID-19 pneumonia. The tofacitinib trial was a research collaboration between Pfizer and the Academic Research Organization from the Hospital Israelita Albert Einstein, which was the regulatory sponsor and clinical trial coordinating center.